Standard Chartered Plans to Cut Over 15 of Corporate Functions Roles Amid Push for Higher Returns Lowes Warns of Shifting Consumer Sentiment Amid Housing Market Headwinds Amazon Stock Rides Cloud and Retail Demand as Magnificent Seven Diverges Goldman Sachs Advocates Dividend Stocks and Buffer ETFs as Market Valuations Soar Coherent Corp Reports Q3 Fiscal 2026 Results Market Awaits Details on Revenue and Earnings Nifty Futures Hold Above Base as AdvanceDecline Ratio Shows Positive Bias Zomato Tata Motors Lead Gains ZION Q1 2026 Earnings EPS Surprises to the Upside Amid Steady Banking Performance Passage Bio Inc PASG Q1 2026 Earnings NarrowerThanExpected Loss Fuels Share Gains AQST Q1 2026 Earnings Narrower Loss Beats Estimates as Company Progresses Pipeline Hillman Solutions Corp HLMN Q1 2026 Earnings EPS Misses Estimates as Operational Costs Weigh on Results Navient Corporation JSM Q1 2026 Earnings EPS Surges Past Estimates Amid Mixed Operational Signals Coeur Mining CDE Q1 2026 Earnings EPS Miss Highlights Cost Pressures on Bottom Line Core AI Holdings CHAI Declines 089 Holds Above Key Support at 105 Chevron CVX Slides 35 as Energy Sector Faces Headwinds Key Levels to Watch Ethan Allen Interiors ETD Holds Near Support as Modest Gains Signal Stability CocaCola Europacific Partners CCEP Holds Steady Near Support Amid Modest Decline PMTV Remains Unchanged at 2523 as Bond Markets Digest Mixed Signals HFWA Q1 2026 Earnings EPS Surpasses Estimates by 343 as Stock Edges Higher NextNRG Inc Q1 2026 Earnings Narrowing Losses Exceed Expectations Amid Strategic Progress SOFI Q1 2026 Earnings EPS Just Below Consensus Shares Edge Lower Ark Restaurants Q4 2025 Earnings Net Loss Reported No Revenue Detail Disclosed IN8bio Q1 2026 Earnings EPS Beat Drives Modest Stock Gain as Development Costs Remain under Control Soligenix SNGX Q1 2026 Earnings NarrowerThanExpected Loss Beats Estimates Stock Slips Paul Tudor Jones No Chance Warsh Gets Fed Rate Cut DCTH Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Progress Kura Oncology KURA Edges Higher Amid Broader Biotech Momentum